Science
Mechanism of Action
This peptide primarily functions by interfering with the melanogenesis pathway, reducing hyperpigmentation at multiple levels. It competitively binds to receptors on melanocytes, diminishing the stimulatory effect of α-MSH on melanin synthesis. Furthermore, Tetrapeptide-27 decreases the production of POMC, α-MSH, and interleukins within keratinocytes, substances often induced by factors like UV exposure or hormonal changes. A key aspect of its action is the direct inhibition of tyrosinase, the rate-limiting enzyme in melanin formation, with reported efficacy surpassing that of Arbutin. Beyond pigment control, it offers comprehensive skin conditioning, contributing to a softer, smoother, and more supple skin appearance by improving overall texture and hydration.
Research
Clinical Evidence
Medium confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
Tetrapeptide-27 is generally considered safe for topical cosmetic application. However, data regarding its usage during pregnancy and breastfeeding are limited; individuals in these categories are advised to consult a healthcare professional. While adverse reactions are generally uncommon, potential side effects such as skin irritation, redness, or allergic reactions can occur, making a patch test advisable before widespread use.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Tetrapeptide-27 is a valuable multi-functional peptide, effectively targeting hyperpigmentation through melanin inhibition and tyrosinase suppression, while also enhancing skin brightness, texture, and providing conditioning benefits across all skin types.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources